Browse 13366 Federal Education Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Education grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
| Close Date | Grant Title | Agency |
| November 15th, 2024 |
Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) |
National Institutes of Health |
| November 15th, 2024 |
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) |
National Institutes of Health |
| November 15th, 2024 |
Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional) |
National Institutes of Health |
| May 1st, 2024 |
2024-25 EdUSA Opportunity Funds Program for Graduate Study |
US Mission to Venezuela |
| March 1st, 2024 |
EducationUSA Professional College Counselor Network Program |
US Mission to Venezuela |
| January 7th, 2027 |
Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| February 15th, 2024 |
Alumni Engagement Innovation Fund (AEIF 2024) |
US Mission to Georgia |
| May 7th, 2027 |
Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional) |
National Institutes of Health |
| May 7th, 2027 |
Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional) |
National Institutes of Health |
| December 29th, 2023 |
RFI 72069624RFI00001 : USAID/Rwanda Strengthening Equitable Education for the Deaf (SEED) Activity |
Burundi USAID Bujumbura |
| March 1st, 2024 |
GOMO ARP - Enhancing Arctic Data Management and Development of Data-Driven Products and Tools for Climate Resilience under the Inflation Reduction Act (IRA) |
Department of Commerce |
| February 20th, 2026 |
Assessment of Climate at Institutions (ACt) Award (RC2 - Clinical Trial Not Allowed) |
National Institutes of Health |
| February 23rd, 2026 |
Integrated Functional Mapping and Molecular Profiling of Cell Ensembles Encoding the Effects of Addictive Substances in Rodents (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| November 14th, 2024 |
Interplay of Autophagy Regulated Cell Death and HIV Pathogenesis in Substance Use Disorders (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
| November 14th, 2024 |
Interplay of Autophagy Regulated Cell Death and HIV Pathogenesis in Substance Use Disorders (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| March 6th, 2024 |
Cancer Adoptive Cellular Therapy Network (Can-ACT) for Pediatric Cancers (UG3/UH3 Clinical Trial Required) |
National Institutes of Health |
| March 20th, 2026 |
Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional) |
National Institutes of Health |
| March 26th, 2024 |
Office of Special Education and Rehabilitative Services (OSERS): rehabilitation Services Administration (RSA): American Indian Vocational Rehabilitation Services, Assistance Listing Number (ALN) 84.250Q |
Department of Education |
| February 20th, 2024 |
OSERS: OSEP: Personnel Preparation of Special Education, Early Intervention, and Related Services Personnel at Historically Black Colleges and Universities, Tribally Controlled Colleges and Universities, and Other |
Department of Education |
| January 22nd, 2024 |
USAID My Education Activity (Taleemi Activity) |
Middle East Regional Platform USAID MERP |
|
| January 7th, 2027 |
Addressing Health and Health Care Disparities among Sexual and Gender Minority Populations (R01 - Clinical Trials Optional) |
National Institutes of Health |
| August 31st, 2024 |
U.S. Embassy La Paz PD Annual Program Statement |
US Mission to Bolivia |
| November 1st, 2025 |
IVV S2S Testing - Do not submit |
IV V Test Agency |
| November 13th, 2026 |
Providing Research Education Experiences to Enhance Inclusivity for a Diverse Substance Use and Addiction Scientific Workforce (R25 Clinical Trials Not Allowed) |
National Institutes of Health |
| October 1st, 2024 |
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) |
National Institutes of Health |
| February 20th, 2024 |
2024 Alumni Engagement Innovation Fund |
US Mission to Bosnia and Herzegovina |
| November 28th, 2024 |
Targeting The Learning Crisis |
Uganda USAID Kampala |
| March 1st, 2024 |
BRAIN Initiative: Marmoset Coordination Center (U24 Clinical Trials Not Allowed) |
National Institutes of Health |
| March 1st, 2024 |
BRAIN Initiative: Marmoset Colonies for Neuroscience Research (U24 Clinical Trials Not Allowed) |
National Institutes of Health |
| February 15th, 2024 |
BRAIN Initiative: Brain-Behavior Quantification and Synchronization Transformative and Integrative Models of Behavior at the Organismal Level (R34 Clinical Trial Optional) |
National Institutes of Health |
| October 1st, 2024 |
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P30 Clinical Trial Optional) |
National Institutes of Health |
| October 1st, 2024 |
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional) |
National Institutes of Health |
| October 1st, 2024 |
Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) |
National Institutes of Health |
| October 1st, 2024 |
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional) |
National Institutes of Health |
| October 1st, 2024 |
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) |
National Institutes of Health |
| October 1st, 2024 |
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) |
National Institutes of Health |
| October 1st, 2024 |
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) |
National Institutes of Health |
| March 7th, 2024 |
Office of Elementary and Secondary Education (OESE): Office of Indian Education (OIE)::Indian Education Discretionary Grant Programs: Native American Language Education Program, Assistance Listing Number (ALN) 84.415B |
Department of Education |
| March 15th, 2024 |
Career Enhancement Award to Advance Research on Firearm Injury and Mortality Prevention (K18 Independent Clinical Trial Required) |
National Institutes of Health |
| March 15th, 2024 |
Career Enhancement Award to Advance Research on Firearm Injury and Mortality Prevention (K18 Independent Clinical Trial Not Allowed} |
National Institutes of Health |
